Cargando…

Accelerated Disease Onset with Stabilized Familial Amyotrophic Lateral Sclerosis (ALS)-linked Mutant TDP-43 Proteins

Abnormal protein accumulation is a pathological hallmark of neurodegenerative diseases, including accumulation of TAR DNA-binding protein 43 (TDP-43) in amyotrophic lateral sclerosis (ALS). Dominant mutations in the TDP-43 gene are causative for familial ALS; however, the relationship between mutant...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Shoji, Kaneko, Kumi, Yamanaka, Koji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561582/
https://www.ncbi.nlm.nih.gov/pubmed/23235148
http://dx.doi.org/10.1074/jbc.M112.433615
_version_ 1782257984004423680
author Watanabe, Shoji
Kaneko, Kumi
Yamanaka, Koji
author_facet Watanabe, Shoji
Kaneko, Kumi
Yamanaka, Koji
author_sort Watanabe, Shoji
collection PubMed
description Abnormal protein accumulation is a pathological hallmark of neurodegenerative diseases, including accumulation of TAR DNA-binding protein 43 (TDP-43) in amyotrophic lateral sclerosis (ALS). Dominant mutations in the TDP-43 gene are causative for familial ALS; however, the relationship between mutant protein biochemical phenotypes and disease course and their significance to disease pathomechanism are not known. Here, we found that longer half-lives of mutant proteins correlated with accelerated disease onset. Based on our findings, we established a cell model in which chronic stabilization of wild-type TDP-43 protein provoked cytotoxicity and recapitulated pathogenic protein cleavage and insolubility to the detergent Sarkosyl, TDP-43 properties that have been observed in sporadic ALS lesions. Furthermore, these cells showed proteasomal impairment and dysregulation of their own mRNA levels. These results suggest that chronically increased stability of mutant or wild-type TDP-43 proteins results in a gain of toxicity through abnormal proteostasis.
format Online
Article
Text
id pubmed-3561582
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher American Society for Biochemistry and Molecular Biology
record_format MEDLINE/PubMed
spelling pubmed-35615822013-02-01 Accelerated Disease Onset with Stabilized Familial Amyotrophic Lateral Sclerosis (ALS)-linked Mutant TDP-43 Proteins Watanabe, Shoji Kaneko, Kumi Yamanaka, Koji J Biol Chem Molecular Bases of Disease Abnormal protein accumulation is a pathological hallmark of neurodegenerative diseases, including accumulation of TAR DNA-binding protein 43 (TDP-43) in amyotrophic lateral sclerosis (ALS). Dominant mutations in the TDP-43 gene are causative for familial ALS; however, the relationship between mutant protein biochemical phenotypes and disease course and their significance to disease pathomechanism are not known. Here, we found that longer half-lives of mutant proteins correlated with accelerated disease onset. Based on our findings, we established a cell model in which chronic stabilization of wild-type TDP-43 protein provoked cytotoxicity and recapitulated pathogenic protein cleavage and insolubility to the detergent Sarkosyl, TDP-43 properties that have been observed in sporadic ALS lesions. Furthermore, these cells showed proteasomal impairment and dysregulation of their own mRNA levels. These results suggest that chronically increased stability of mutant or wild-type TDP-43 proteins results in a gain of toxicity through abnormal proteostasis. American Society for Biochemistry and Molecular Biology 2013-02-01 2012-12-12 /pmc/articles/PMC3561582/ /pubmed/23235148 http://dx.doi.org/10.1074/jbc.M112.433615 Text en © 2013 by The American Society for Biochemistry and Molecular Biology, Inc. Author's Choice—Final version full access. Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) applies to Author Choice Articles
spellingShingle Molecular Bases of Disease
Watanabe, Shoji
Kaneko, Kumi
Yamanaka, Koji
Accelerated Disease Onset with Stabilized Familial Amyotrophic Lateral Sclerosis (ALS)-linked Mutant TDP-43 Proteins
title Accelerated Disease Onset with Stabilized Familial Amyotrophic Lateral Sclerosis (ALS)-linked Mutant TDP-43 Proteins
title_full Accelerated Disease Onset with Stabilized Familial Amyotrophic Lateral Sclerosis (ALS)-linked Mutant TDP-43 Proteins
title_fullStr Accelerated Disease Onset with Stabilized Familial Amyotrophic Lateral Sclerosis (ALS)-linked Mutant TDP-43 Proteins
title_full_unstemmed Accelerated Disease Onset with Stabilized Familial Amyotrophic Lateral Sclerosis (ALS)-linked Mutant TDP-43 Proteins
title_short Accelerated Disease Onset with Stabilized Familial Amyotrophic Lateral Sclerosis (ALS)-linked Mutant TDP-43 Proteins
title_sort accelerated disease onset with stabilized familial amyotrophic lateral sclerosis (als)-linked mutant tdp-43 proteins
topic Molecular Bases of Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561582/
https://www.ncbi.nlm.nih.gov/pubmed/23235148
http://dx.doi.org/10.1074/jbc.M112.433615
work_keys_str_mv AT watanabeshoji accelerateddiseaseonsetwithstabilizedfamilialamyotrophiclateralsclerosisalslinkedmutanttdp43proteins
AT kanekokumi accelerateddiseaseonsetwithstabilizedfamilialamyotrophiclateralsclerosisalslinkedmutanttdp43proteins
AT yamanakakoji accelerateddiseaseonsetwithstabilizedfamilialamyotrophiclateralsclerosisalslinkedmutanttdp43proteins